Skip to main content

INM

InMed Pharmaceuticals Inc.

Company with tickers: INM

CIK
1728328
CUSIP
457637700
Shares Outstanding
3,314,063
13F Activity (30d)
5 filings 5 filers

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 9
Total Value: $205,948
Total Shares: 319,307

Institutional Ownership Trend

6 quarters

Holder Concentration

Across 9 13F filers · Δ vs Dec 31, 2025
Top Holder
69.0%
Dec 2024 → Mar 2026 · range 69.0% – 95.2%
−19.8 pts
Top 5
98.3%
Dec 2024 → Mar 2026 · range 98.3% – 100.0%
−1.7 pts
Top 10
100.0%
Dec 2024 → Mar 2026 · range 100.0% – 100.0%
0.0 pts
HHI
5,057
Dec 2024 → Mar 2026 · range 5,057 – 9,085
Highly concentrated −2,889

Quarterly Activity

vs Dec 31, 2025
New
4
Increased
2
Decreased
0
Sold Out
2
Unchanged
3
Holder count: +2
Institutional value: -14.4%
Shares held: +40.6%

Top Buyers

vs Dec 31, 2025
Institution Added Now Holds Open

Top Sellers

vs Dec 31, 2025
No qualifying movers this quarter.

Top New Positions

vs Dec 31, 2025
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Dec 31, 2025
Institution Previously Held Last Value (USD) Open
Showing 9 of 9
Export CSV
Holder Value (USD) % of 13F Shares Open